RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that educational activities and numerous presentations describing the investigation of several of the Company’s products – including rifaximin, RELISTOR®, APRISO™ and MOVIPREP® -- will occur during the American College of Gastroenterology 2011 Annual Scientific Meeting. ACG 2011 is being held in Washington, DC, October 28 – November 2, 2011.
